Following these steps ensures optimal performance and longevity
6 A 2019 randomised control trial found no adverse events related to either nicotine replacement therapy (NRT) or ENDS but did find that NRT users were more likely to report nausea (37.9% versus 31.3% of ENDS users) while ENDS users were more likely to report mouth or throat irritation (65.3% versus 51.2% of NRT users)
It was valued at US$ 5.4 Bn in 2023 It is expected to reach US$ 119.2 Bn by 2034 Rise in awareness of the harmful effect of tobacco products and convenience of use The flavored segment contributes the largest share North America is booming as consumers are mainly transitioning to smokeless nicotine alternatives due to health concerns British American Tobacco (VELLO), Swedish Match (ZYN), Skruf, Nordic Spirit, Rogue, 77 Nicotine Pouches, Genmist, Stockholm White, NIIN, and Triumph Chew 1
This included face-to-face stop smoking services and national advocacy services to ensure they can best help achieve the Smokefree Aotearoa New Zealand 2025 goal
Amid pressure from health advocates, President John F
